Adelaide Co., Ltd. acquired 2.1% stake in Lumimicro Co., Ltd from Retriever Union No. 2 for KRW 2.8 billion.
November 22, 2018
Share
Adelaide Co., Ltd. acquired 2.1% stake in Lumimicro Co., Ltd (KOSDAQ:A082800) from Retriever Union No. 2 for KRW 2.8 billion on November 15, 2018. Under the terms of the transaction, Adelaide Co., Ltd. acquired 1.5 million shares at KRW 1,850 per share.
Adelaide Co., Ltd. completed the acquisition of 2.1% stake in Lumimicro Co., Ltd (KOSDAQ:A082800) from Retriever Union No. 2 on November 15, 2018.
Vivozon Pharmaceutical Co Ltd , formerly Vivozon Healthcare Inc, is a Korea-based company mainly engaged in the manufacture and sale of finished pharmaceutical products. The Company operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
VIVOZON PHARMACEUTICAL CO., LTD. 
